Unlock instant, AI-driven research and patent intelligence for your innovation.

Gemcitabine ProTide anaerobic activated pro-drug and application thereof

A technology of gemcitabine and oxygen activation, applied in organic chemistry, anti-tumor drugs, drug combinations, etc., can solve the problem of limited tumor effect, achieve small cell toxicity, large cell toxicity, and good anti-tumor effect

Inactive Publication Date: 2017-11-24
JIANGSU QIANZHIKANG BIOLOGICAL MEDICINE SCI & TECH CO LTD
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Traditional antineoplastic drugs have good lethality against tumors near blood vessels, but have limited effect on tumors in hypoxic areas

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gemcitabine ProTide anaerobic activated pro-drug and application thereof
  • Gemcitabine ProTide anaerobic activated pro-drug and application thereof
  • Gemcitabine ProTide anaerobic activated pro-drug and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Embodiment 1: the synthesis of target compound 001-021:

[0033] Synthesis of Compound 001

[0034]

[0035] Synthesis of 3'-O-(tert-butoxycarbonyl)gemcitabine

[0036] Synthetic route (obtained by reference method, The Journal of Organic Chemistry, 1999, 64:8319-8322):

[0037]

[0038] Experimental operation: gemcitabine (gemcitabine, 0.60g, 2mmol), Na 2 CO3 (1.06g), 40mL dioxane, 40mL water, di-tert-butyl dicarbonate (DBDC, 0.44g, 2mmol) were stirred at room temperature for 48 hours. Add 20mL water, extract with 2×300mL ethyl acetate, Na 2 SO 4 Dry and concentrate under reduced pressure. Flash column chromatography (CH 2 Cl 2 -Ethyl acetate-EtOH 1:1:0.02) gave 3'-O-(N-tert-butoxycarbonyl)gemcitabine (0.60 g). 1 H NMR(DMSO-d6,300MHz)δ(ppm):7.64(d,1H)7.40(d,2H),6.21(t,1H),5.81(d,1H),5.25-5.12(m,2H), 4.13(t,1H)3.71-3.60(m,2H),1,45(s,9H).

[0039] Synthetic route (obtained by reference method, The Journal of Medicinal Chemistry, 2014, 57:1531-1542):

[0...

Embodiment 2

[0103] Example 2: In vitro inhibitory effect of the target compound on tumor cell proliferation under normoxic and hypoxic conditions

[0104] Take tumor cells in the logarithmic growth phase, add 0.25% trypsin to digest for 3 minutes, suspend the cells with RPMI-1640 containing 10% calf serum, count them, and adjust the cell concentration to 1×10 5 cells / mL, inoculate 100 μL / well in Top-count dedicated 96-well cell culture plate, 37°C, 5% CO 2 Incubate for 24h. Then the cells were divided into experimental group and control group, and the experimental group was added with target compound solution (0.001 μg / mL, 0.01 μg / mL, 0.1 μg / mL, 1 μg / mL, 10 μg / mL), each concentration was quadruple well , and the volume of each well was supplemented with 200 μL. Each group was cultured for 72 hours after sample addition (hypoxia group was stored in 5% CO 2 , 95%N 2 Continue to culture for 72h respectively), before the end of culture, each well was added 3 H-TdR 3×10 5 Bq, use Top-cou...

Embodiment 3

[0109] Example 3: Inhibitory effect of target compound on orthotopic xenograft tumor of human BxPC-3 nude mice

[0110] BxPC-3 human pancreatic cancer cells in the logarithmic growth phase were taken in 5×10 6 1 cell·0.2mL -1 ·Only -1 The concentration was inoculated subcutaneously on the back of nude mice to establish a nude mouse subcutaneous xenograft tumor model of human primary pancreatic cancer. After the subcutaneous xenograft tumor had grown to 1 cm, it was taken out, and the central necrotic tissue was removed under sterile conditions, and the surrounding healthy tumor tissue was selected and cut into 1mm 3 organization block.

[0111] Surgical orthotopic transplantation model preparation: intraperitoneally anesthetized nude mice with pentobarbital sodium (50 mg / Kg), made an incision next to the left upper rectus abdominis muscle, exposed the spleen and pancreatic tail, cut the pancreatic capsule, and implanted the tumor block near the splenic artery near the pancr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a gemcitabine ProTide anaerobic activated pro-drug and application thereof. The structural general molecular formula of the gemcitabine ProTide anaerobic activated pro-drug is shown in the specification, wherein one of R<1> and R<2> is an anaerobic activated group of -C(R3R4)ArNO2, and the other one is an alkyl group, a phenyl group or -CH2Ar which contains 1 to 6 carbon atoms; R<3> and R<4> are -Hs or methyl groups; Ar is an aromatic ring compound. The gemcitabine ProTide anaerobic activated pro-drug disclosed by the invention has stronger cytotoxicity in an anaerobic condition, has excellent anti-tumour effect and good safety, can achieve a good anti-tumour effect by combining with other anti-tumour drugs for use, and can be used for preparation of an anti-tumour drug.

Description

technical field [0001] The invention belongs to the field of pharmacy and provides a class of gemcitabine ProTide hypoxia-activated prodrug and application thereof. Background technique [0002] Gemcitabine is a nucleoside antineoplastic drug. The mechanism of action of this type of drug is to antagonize nucleotide metabolism. After intracellular triphosphorylation in vivo, it inhibits the synthesis of deoxynucleoside triphosphates (dNTPs) Or RNA molecules interfere with cell replication, competitively inhibit DNA polymerase, etc., specifically interfere with the metabolism of nucleic acids, prevent cell division and reproduction, and eventually lead to tumor cell death. Nucleoside antitumor drugs are prone to drug resistance, and its ProTide prodrug can reduce the occurrence of drug resistance and has a good antitumor effect. Among them, the gemcitabine ProTide prodrug NUC-1031 has entered clinical research (Journal of Medicinal Chemistry 2014, 57, 1531 -1542). However, P...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07H19/10A61K31/7068A61P35/00
CPCA61K31/7068C07H1/00C07H1/02C07H19/10A61K2300/00A61P35/00
Inventor 李飞
Owner JIANGSU QIANZHIKANG BIOLOGICAL MEDICINE SCI & TECH CO LTD